Two Promising SARS-CoV-2 Blocking Compounds Undergo Testing

Impact BioMedical announces that two compound candidates—Linebacker and Equivir—may show promise in the fight against SARS-CoV-2. The compounds, which were identified through molecular docking studies utilizing advanced computational models, will now undergo testing to confirm the prediction. The news comes from Singapore eDevelopment, the parent company of its U.S. […]

Click here to view original web page at